Healthpeak Properties, Inc. (DOC) KPIs and segments
Close on Nov 16, 2026Market cap $13.68BP/E 56.7Yield 6.15%
KPI & bộ phận
Chỉ số vận hành và bộ phận làm nên hoạt động của Healthpeak Properties · năm tài chính kết thúc ngày 31 tháng 12
Nhìn nhanh KPI của Healthpeak Properties: 40 chỉ số vận hành, trong đó có Total Portfolio Properties, Outpatient Medical — Total Rentable Capacity và Lab — Total Rentable Capacity, lấy từ 426 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.
Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.
Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.
| Thêm vào biểu đồ | Chỉ số | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Outpatient Medical Buildings($M) | 327 | 320 | 321 | 318 | 333 | 238 | |||||||
Outpatient medical($M) | 311 | 318 | 315 | 314 | |||||||||
Senior housing($M) | 216 | 200 | 149 | 149 | |||||||||
Lab($M) | 216 | 213 | 213 | 209 | 218 | 226 | 214 | 224 | 223 | ||||
CCRC($M) | 150 | 149 | 149 | 146 | 143 | 141 | 139 | 136 | |||||
Kỳ báo cáo trước đây (báo cáo lần cuối 2024)1 | |||||||||||||
Kỳ báo cáo trước đây (báo cáo lần cuối 2024)4 | |||||||||||||
Kỳ báo cáo trước đây (báo cáo lần cuối 2024)4 | |||||||||||||
Kỳ báo cáo trước đây (báo cáo lần cuối 2023)1 | |||||||||||||
Kỳ báo cáo trước đây (báo cáo lần cuối 2025)3 | |||||||||||||
Total Portfolio Properties5 | 726 | 686 | 688 | 689 | 703 | 702 | 700 | 697 | 700 | 758 | 774 | ||
Operating Properties | 696 | 657 | 656 | ||||||||||
Development & Redevelopment Properties | 30 | 29 | 32 | ||||||||||
Outpatient Medical Properties2 | 506 | 501 | 504 | 509 | 530 | 529 | 527 | 524 | 527 | 585 | 594 | 294 | |
Outpatient Medical — Operating Properties | 495 | 492 | 495 | 500 | 524 | 522 | 521 | 519 | 520 | 579 | 589 | 294 | |
Outpatient Medical — Development & Redevelopment | 11 | 9 | 9 | ||||||||||
Lab (Life Science) Properties2 | 143 | 141 | 141 | 146 | 139 | 139 | 139 | 139 | 139 | 139 | 146 | 131 | |
Lab — Operating Properties | 124 | 121 | 118 | 124 | 115 | 113 | 109 | 111 | 118 | 120 | 125 | 131 | |
Lab — Development & Redevelopment | 19 | 20 | 23 | ||||||||||
Senior Housing Communities | 74 | 41 | 40 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | |
Outpatient Medical — Total Rentable Capacity(nghìn ft²)6 | 35,914.0 | 35,758.0 | 36,100.0 | 37,019.0 | 37,784.0 | 37,791.0 | 37,030.0 | 37,048.0 | 37,043.0 | 39,702.0 | 40,131.0 | ||
Operating Rentable Square Feet(nghìn ft²) | 34,984.0 | 34,958.0 | 35,300.0 | 36,477.0 | 37,268.0 | 37,105.0 | 37,030.0 | 37,048.0 | 37,043.0 | 39,702.0 | 40,131.0 | ||
Occupied Square Feet(nghìn ft²) | 32,414.0 | 32,330.0 | 32,415.0 | ||||||||||
Same-Store Pool Square Feet(nghìn ft²) | 34,046.0 | 34,039.0 | 34,037.0 | 34,039.0 | 34,037.0 | 34,149.0 | 7,896.0 | 35,160.0 | 36,399.0 | 36,317.0 | 36,316.0 | 36,532.0 | |
Development & Redevelopment Capacity(nghìn ft²) | 930.0 | 800.0 | 800.0 | ||||||||||
Fee-Simple Owned Square Feet(nghìn ft²) | 15,599.0 | 15,476.0 | 18,487.0 | ||||||||||
Hospital Ground-Leased Square Feet(nghìn ft²) | 20,315.0 | 20,282.0 | 17,614.0 | ||||||||||
Lab — Total Rentable Capacity(nghìn ft²)5 | 12,617.0 | 12,387.0 | 12,373.0 | 12,835.0 | 11,480.0 | 11,462.0 | 9,653.0 | 9,716.0 | 9,974.0 | 10,031.0 | 10,516.0 | 10,959.0 | |
Operating Rentable Square Feet(nghìn ft²) | 10,650.0 | 10,228.0 | 9,807.0 | 11,406.0 | 10,004.0 | 9,762.0 | 9,653.0 | 9,716.0 | 9,974.0 | 10,031.0 | 10,516.0 | ||
Occupied Square Feet(nghìn ft²) | 9,829.0 | 9,604.0 | 9,507.0 | ||||||||||
Same-Store Pool Square Feet(nghìn ft²) | 7,963.0 | 7,969.0 | 7,956.0 | 7,956.0 | 7,956.0 | 7,846.0 | 7,896.0 | 7,953.0 | 8,101.0 | ||||
Development & Redevelopment Capacity(nghìn ft²) | 1,966.0 | 2,159.0 | 2,566.0 | ||||||||||
Fee-Simple Owned Square Feet(nghìn ft²) | 12,617.0 | 12,387.0 | 12,373.0 | ||||||||||
Senior Housing — Total Portfolio Units1 | 15,256 | 11,420 | 11,252 | 7,067 | 7,067 | 7,065 | 7,064 | 7,060 | 7,060 | 7,061 | 7,088 | ||
Same-Store Senior Housing Units | 7,029 | 7,067 | 7,069 | 7,067 | 7,067 | 7,065 | 7,064 | 7,060 | 7,060 | 7,061 | 7,088 | 7,085 | |
Outpatient Medical — Portfolio Occupancy Rate(%)5 | 90.3% | 90.7% | 90.5% | 90.6% | 90.6% | 90.5% | 92.2% | 92.2% | 92.2% | 92.1% | 92.0% | ||
Same-Store Occupancy Rate(%) | 91.7% | 91.6% | 91.6% | 91.8% | 91.7% | 92.4% | 97.8% | 92.6% | 92.5% | 92.7% | 92.5% | 92.3% | |
Fee-Simple Ownership Share of Sq. Ft.(%) | 43.4% | 43.3% | 51.2% | ||||||||||
Weighted Average Remaining Lease Term (WALT) | 66.00 | 65.00 | 66.00 | ||||||||||
Average Annual Contractual Rent Escalator(%) | 2.8% | 2.8% | 2.7% | ||||||||||
Fixed Contractual Escalator Share of Leases(%) | 95.8% | 95.8% | 95.6% | ||||||||||
Lab — Portfolio Occupancy Rate(%)6 | 79.8% | 78.5% | 77.7% | 77.1% | 81.0% | 82.2% | 83.7% | 97.5% | 95.7% | 95.4% | 96.0% | 96.9% | |
Same-Store Occupancy Rate(%) | 90.6% | 90.4% | 90.1% | 89.9% | 92.7% | 94.4% | 97.8% | 97.8% | 97.7% | ||||
Triple-Net (NNN) Lease Share of Occupied Sq. Ft.(%) | 89.8% | 90.1% | 89.7% | ||||||||||
Fee-Simple Ownership Share of Sq. Ft.(%) | 100.0% | 100.0% | 100.0% | ||||||||||
Weighted Average Remaining Lease Term (WALT) | 67.00 | 68.00 | 68.00 | ||||||||||
Average Annual Contractual Rent Escalator(%) | 3.2% | 3.2% | 3.2% | ||||||||||
Fixed Contractual Escalator Share of Leases(%) | 100.0% | 100.0% | 100.0% | ||||||||||
Senior Housing — Portfolio Occupancy Rate(%)1 | 86.5% | 85.5% | 86.1% | 87.4% | 86.7% | 86.0% | 86.2% | 85.8% | 85.2% | 85.4% | 85.2% | ||
Same-Store Occupancy Rate(%) | 89.7% | 88.6% | 88.5% | 87.4% | 86.7% | 86.0% | 86.2% | 85.8% | 85.2% | 85.4% | 85.2% | 84.9% | |
Outpatient Medical — Renewal Cash Releasing Spread(%)5 | 4.5% | 4.9% | 5.4% | 4.4% | 5.4% | 5.9% | 4.1% | 6.8% | 7.8% | 4.0% | 3.4% | 3.6% | |
Trailing 12-Month Tenant Retention Rate(%) | 81.7% | 80.1% | 79.1% | 78.5% | 76.2% | 84.8% | 85.5% | 88.2% | 88.8% | 83.2% | 84.1% | ||
Executed Lease Volume (Signed)(nghìn ft²)2 | 846.0 | 1,243.0 | 1,063.0 | 1,738.0 | 1,165.0 | 1,035.0 | |||||||
New Lease Share of Executions(%) | 26.0% | 26.0% | 18.0% | 17.0% | 23.0% | 18.0% | |||||||
Renewal Share of Executions(%) | 74.0% | 74.0% | 82.0% | 83.0% | 77.0% | 82.0% | |||||||
New Lease Commencements(nghìn ft²)5 | 362.0 | 252.0 | 199.0 | 299.0 | 348.0 | 308.0 | 232.0 | 807.0 | 594.0 | 376.0 | 120.0 | 212.0 | |
New Lease Annualized Base Rent per Sq. Ft.($) | 32.41 | 27.24 | 26.83 | 29.16 | 28.13 | 28.94 | 26.86 | 27.99 | 28.22 | 29.19 | 29.94 | 28.61 | |
New Lease Average Term | 135.00 | 94.00 | 87.00 | 84.00 | 107.00 | 116.00 | 87.00 | 94.00 | 98.00 | 96.00 | 80.00 | ||
New Lease Tenant Improvements per Sq. Ft. / Yr($) | 4.20 | 4.51 | 4.14 | 3.86 | 4.47 | 3.34 | |||||||
New Lease Commissions per Sq. Ft. / Yr($) | 1.48 | 1.30 | 1.58 | 1.29 | 1.31 | 1.25 | |||||||
New Lease Costs % of Annual Base Rent(%) | 17.5% | 21.3% | 21.3% | 17.7% | 20.5% | 15.9% | |||||||
Renewal Commencements — Annualized Base Rent per Sq. Ft.($)3 | 27.35 | 31.36 | 28.51 | 29.80 | 28.79 | 31.82 | 30.43 | 27.08 | 26.59 | 28.33 | 28.24 | 29.34 | |
Renewal Average Lease Term | 82.00 | 65.00 | 74.00 | 105.00 | 63.00 | 71.00 | 68.00 | 81.00 | 83.00 | 76.00 | 90.00 | ||
Renewal Tenant Improvements per Sq. Ft. / Yr($) | 1.84 | 1.83 | 1.44 | 1.61 | 1.41 | 2.15 | |||||||
Renewal Commissions per Sq. Ft. / Yr($) | 0.76 | 1.26 | 0.54 | 0.71 | 0.60 | 1.10 | |||||||
Non-Renewals & Tenant Vacates(nghìn ft²) | 298.0 | 202.0 | 288.0 | 235.0 | 474.0 | 370.0 | |||||||
Lab — Renewal Cash Releasing Spread(%)5 | -5.6% | -7.3% | 3.5% | -1.7% | 4.6% | 6.1% | 4.7% | 11.4% | 6.7% | 5.8% | 2.6% | -7.6% | |
Trailing 12-Month Tenant Retention Rate(%) | 55.7% | 50.5% | 69.0% | 71.6% | 83.0% | 86.5% | 88.2% | 78.2% | 71.6% | 73.2% | 21.6% | ||
Executed Lease Volume (Signed)(nghìn ft²)2 | 480.0 | 381.0 | 141.0 | 333.0 | 339.0 | 486.0 | |||||||
New Lease Share of Executions(%) | 70.0% | 58.0% | 92.0% | 78.0% | 45.0% | 13.0% | |||||||
Renewal Share of Executions(%) | 30.0% | 42.0% | 8.0% | 22.0% | 55.0% | 87.0% | |||||||
New Lease Commencements(nghìn ft²)5 | 276.0 | 303.0 | 49.0 | 317.0 | 362.0 | 230.0 | 149.0 | 904.0 | 817.0 | 576.0 | 312.0 | 19.0 | |
New Lease Annualized Base Rent per Sq. Ft.($) | 44.28 | 58.14 | 56.26 | 56.48 | 68.61 | 51.53 | 59.63 | 66.41 | 66.05 | 71.63 | 70.52 | 80.85 | |
New Lease Average Term | 115.00 | 110.00 | 57.00 | 71.00 | 114.00 | 94.00 | 58.00 | 100.00 | 99.00 | 106.00 | 117.00 | ||
New Lease Tenant Improvements per Sq. Ft. / Yr($) | 13.50 | 18.93 | 4.41 | 11.96 | 15.73 | 13.34 | |||||||
New Lease Commissions per Sq. Ft. / Yr($) | 2.63 | 3.30 | 3.31 | 3.25 | 3.18 | 2.69 | |||||||
New Lease Costs % of Annual Base Rent(%) | 36.4% | 38.2% | 13.7% | 26.9% | 27.6% | 31.1% | |||||||
Renewal Commencements — Annualized Base Rent per Sq. Ft.($)3 | 72.22 | 46.48 | 70.70 | 40.35 | 65.05 | 52.97 | 41.34 | 55.17 | 54.05 | 52.05 | 57.44 | 57.35 | |
Renewal Average Lease Term | 37.00 | 115.00 | 12.00 | 84.00 | 41.00 | 62.00 | 28.00 | 84.00 | 91.00 | 96.00 | 23.00 | ||
Renewal Tenant Improvements per Sq. Ft. / Yr($) | 4.79 | 3.05 | 0 | 0.11 | 1.30 | 3.42 | |||||||
Renewal Commissions per Sq. Ft. / Yr($) | 2.83 | 2.46 | 4 | 3.31 | 2.27 | 2.02 | |||||||
Non-Renewals & Tenant Vacates(nghìn ft²) | 126.0 | 206.0 | 14.0 | 587.0 | 318.0 | 366.0 | |||||||
Total Portfolio — Same-Store Cash NOI YoY Growth(%)6 | 3.6% | 1.8% | 0.0% | 3.9% | 3.5% | 7.0% | 5.4% | 4.5% | |||||
Outpatient Medical — Same-Store Cash NOI YoY Growth(%) | 3.1% | 2.5% | 2.4% | 4.1% | 2.0% | 1.5% | 5.0% | 3.4% | 3.1% | 4.3% | |||
Lab — Same-Store Cash NOI YoY Growth(%) | -0.7% | -3.2% | -7.2% | -0.3% | -3.2% | ||||||||
Senior Housing — Same-Store Cash NOI YoY Growth(%) | 25.9% | 19.2% | 13.8% | 16.7% | 9.4% | 8.6% | 22.3% | 20.5% | 4.7% | ||||
Outpatient Medical — Same-Store Cash Revenue YoY Growth(%) | 1.9% | 3.2% | 3.3% | 4.1% | 4.0% | 2.9% | 4.1% | 4.4% | |||||
Lab — Same-Store Cash Revenue YoY Growth(%) | 0.5% | -2.1% | -3.7% | -2.7% | |||||||||
Senior Housing — Same-Store Cash Revenue YoY Growth(%) | 9.8% | 8.4% | 7.6% | 5.3% | 5.7% | 7.3% | 7.0% | ||||||
Total Portfolio — Same-Store Cash (Adjusted) NOI($M)6 | 319 | 319 | 315 | 319 | 308 | 329 | 336 | 340 | 350 | 343 | 337 | 333 | |
Total Same-Store Pool Properties | 600 | 600 | 600 | 600 | 600 | 600 | 599 | 634 | 639 | 696 | 714 | ||
Total Same-Store Cash Real Estate Revenues($M) | 544 | 536 | 534 | 537 | 528 | 550 | 564 | 596 | 605 | 593 | 585 | 579 | |
Total Same-Store Cash Operating Expenses($M) | 226 | 217 | 219 | 218 | 221 | 220 | 229 | 256 | 259 | 250 | 248 | 246 | |
Outpatient Medical — Same-Store Cash NOI($M)3 | 173 | 173 | 171 | 171 | 168 | 184 | 122 | 184 | 192 | 120 | 187 | 187 | |
Outpatient Medical Same-Store Properties | 482 | 482 | 482 | 482 | 482 | 484 | 101 | 486 | 514 | 513 | 106 | 107 | |
Outpatient Medical Same-Store Cash Revenues($M) | 264 | 261 | 261 | 260 | 259 | 276 | 284 | 281 | 289 | 286 | 284 | 165 | |
Outpatient Medical Same-Store Cash Expenses($M) | 91.0 | 87.9 | 89.5 | 89.5 | 91.2 | 91.4 | 46.2 | 97.3 | 97.6 | 97.0 | 96.4 | 94.2 | |
Lab — Same-Store Cash NOI($M)3 | 114 | 115 | 114 | 119 | 114 | 118 | 122 | 120 | 120 | 123 | 123 | 121 | |
Lab Same-Store Properties | 103 | 103 | 103 | 103 | 103 | 101 | 101 | 102 | 102 | 111 | 111 | 111 | |
Lab Same-Store Cash Revenues($M) | 166 | 163 | 162 | 170 | 165 | 165 | 171 | 171 | 173 | 0.10 | |||
Lab Same-Store Cash Expenses($M) | 52.2 | 47.3 | 48.6 | 50.2 | 50.6 | 46.6 | 46.2 | 48.8 | 52.6 | 50.7 | 49.8 | 52.9 | |
Senior Housing — Same-Store Cash NOI($M)3 | 31.9 | 30.2 | 30.5 | 29.2 | 25.3 | 26.9 | 31.6 | 36.2 | 33.8 | 34.0 | 33.7 | 29.7 | |
Senior Housing Same-Store Communities | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | |
Senior Housing Same-Store Cash Revenues($M) | 114 | 112 | 111 | 108 | 104 | 110 | 122 | 149 | 143 | 141 | 139 | 136 | |
Senior Housing Same-Store Cash Expenses($M) | 82.5 | 81.4 | 80.5 | 78.6 | 78.8 | 82.6 | 90.0 | 110 | 109 | 107 | 105 | 106 | |
Total Portfolio — Segment Adjusted (Cash) NOI($M)5 | 381 | 389 | 398 | 392 | 381 | 387 | |||||||
Outpatient Medical — Total Adjusted NOI($M) | 184 | 198 | 198 | 204 | 200 | 202 | |||||||
Lab — Total Adjusted NOI($M) | 141 | 143 | 141 | 140 | 138 | 143 | 146 | ||||||
Senior Housing — Total Adjusted NOI($M) | 53.7 | 45.9 | 55.4 | 41.9 | 36.6 | 36.6 | |||||||
Other Non-Reportable — Total Adjusted NOI($M) | 2.52 | 2.92 | 3.12 | 5.36 | 5.62 | 5.98 | |||||||
Total Portfolio — GAAP Net Operating Income (NOI)($M)3 | 403 | 410 | 418 | 426 | 407 | 411 | |||||||
Outpatient Medical — GAAP NOI($M) | 193 | 207 | 209 | 215 | 211 | 212 | 0.09 | ||||||
Lab — GAAP NOI($M) | 155 | 155 | 150 | 162 | 154 | 155 | 161 | 0.08 | |||||
Senior Housing — GAAP NOI($M) | 53.2 | 45.9 | 55.4 | 43.5 | 36.6 | 37.4 | 38.7 | 0.10 | |||||
Full-Year 2026 Guidance — Diluted FFO as Adjusted per Share (High)($)13 | 1.78 | 1.77 | 1.75 | ||||||||||
Diluted FFO as Adjusted per Share Guidance (Low)($) | 1.76 | 1.73 | 1.71 | ||||||||||
Diluted GAAP EPS Guidance (Low)($) | 0.39 | 0.48 | 0.46 | ||||||||||
Diluted GAAP EPS Guidance (High)($) | 0.41 | 0.52 | 0.50 | ||||||||||
Total Same-Store Cash NOI Growth Guidance (Low)(%) | 0.5% | 0.0% | -1.0% | ||||||||||
Total Same-Store Cash NOI Growth Guidance (High)(%) | 2.0% | 1.5% | -1.0% | ||||||||||
Outpatient Medical SS Cash NOI Growth Guidance (Low)(%) | 2.5% | 2.0% | 2.0% | ||||||||||
Outpatient Medical SS Cash NOI Growth Guidance (High)(%) | 3.0% | 3.0% | 3.0% | ||||||||||
Lab SS Cash NOI Growth Guidance (Low)(%) | -6.0% | -7.0% | -10.0% | ||||||||||
Lab SS Cash NOI Growth Guidance (High)(%) | -3.0% | -4.0% | -5.0% | ||||||||||
Senior Housing SS Cash NOI Growth Guidance (Low)(%) | 16.0% | 13.0% | 11.0% | ||||||||||
Senior Housing SS Cash NOI Growth Guidance (High)(%) | 19.0% | 17.0% | 15.0% | ||||||||||
Acquisitions & Share Repurchases Guidance($M) | 1,200 | 1,000 | 1,000 | ||||||||||
Dev/Redev & Revenue-Enhancing CapEx Guidance($M) | 400 | 400 | 400 | ||||||||||
San Francisco Bay Area, CA — Quarterly Cash NOI($M)3 | 93.3 | 94.7 | 94.3 | 88.5 | |||||||||
San Francisco Bay Area, CA — % of Portfolio Cash NOI(%) | 23.7% | 23.7% | 23.3% | 23.0% | |||||||||
Boston, MA — Quarterly Cash NOI($M)1 | 33.6 | 35.0 | 34.7 | 35.4 | 35.9 | 39.3 | 37.5 | 2.69 | 2.69 | 2.71 | |||
Boston, MA — % of Portfolio Cash NOI(%) | 8.6% | 8.8% | 8.6% | 9.0% | 9.0% | 10.0% | 10.0% | 10.0% | 10.0% | 10.0% | |||
Dallas, TX — Quarterly Cash NOI($M)1 | 25.1 | 28.4 | 28.0 | 29.7 | 28.2 | 30 | 27.8 | 4.24 | 4.24 | 4.25 | |||
Dallas, TX — % of Portfolio Cash NOI(%) | 6.4% | 7.1% | 6.9% | 8.0% | 7.0% | 8.0% | 7.0% | 9.0% | 8.0% | 7.0% | |||
Health Systems — Annualized Base Rent($M)8 | 541 | 593 | 587 | ||||||||||
Health Systems — % of Portfolio ABR & NOI(%) | 31.6% | 34.5% | 34.4% | ||||||||||
Large-Cap Biopharma (>$10B Market Cap) — Annualized Base Rent / NOI($M)1 | 241 | 226 | 219 | ||||||||||
Large-Cap Biopharma (>$10B Market Cap) — % Share(%) | 14.0% | 13.2% | 12.8% | ||||||||||
Senior Housing (Annualized Adjusted NOI) — Annualized Base Rent / NOI($M)1 | 262 | 222 | 222 | ||||||||||
Senior Housing (Annualized Adjusted NOI) — % Share(%) | 15.3% | 12.9% | 13.0% | ||||||||||
Physician Group Practices — Annualized Base Rent / NOI($M)1 | 207 | 216 | 218 | ||||||||||
Physician Group Practices — % Share(%) | 12.1% | 12.5% | 12.7% | ||||||||||
Medical Device, R&D, University & Other — Annualized Base Rent / NOI($M)1 | 149 | 144 | 147 | ||||||||||
Medical Device, R&D, University & Other — % Share(%) | 8.7% | 8.4% | 8.6% | ||||||||||
Mid-Cap Biopharma ($500M–$10B Market Cap) — Annualized Base Rent / NOI($M)1 | 127 | 120 | 125 | ||||||||||
Mid-Cap Biopharma ($500M–$10B Market Cap) — % Share(%) | 7.4% | 7.0% | 7.3% | ||||||||||
Private Biopharma — Annualized Base Rent / NOI($M)1 | 105 | 119 | 110 | ||||||||||
Private Biopharma — % Share(%) | 6.2% | 6.9% | 6.4% | ||||||||||
Small-Cap Biopharma (<$500M Market Cap) — Annualized Base Rent / NOI($M)1 | 81.1 | 79.6 | 81.7 | ||||||||||
Small-Cap Biopharma (<$500M Market Cap) — % Share(%) | 4.7% | 4.6% | 4.8% | ||||||||||
Top 20 Tenants Combined — Share of Portfolio Annualized Base Rent(%)13 | 34.7% | 34.6% | 34.5% | ||||||||||
Top 20 Tenants — Combined Leased Area(nghìn ft²) | 14,292.0 | 16,066.0 | 14,738.0 | ||||||||||
HCA Healthcare — % of Annualized Base Rent(%)1 | 10.9% | 10.4% | 10.4% | ||||||||||
HCA Healthcare — Leased Area(nghìn ft²) | 5,251.0 | 5,225.0 | 5,198.0 | ||||||||||
CommonSpirit Health (Health System) — % of Annualized Base Rent(%) | 2.4% | 2.5% | 2.4% | ||||||||||
McKesson Corporation (Health System) — % of Annualized Base Rent(%) | 1.2% | 1.4% | 1.5% | ||||||||||
Roche Holding AG (Large-Cap Biopharma) — % of Annualized Base Rent(%) | 1.5% | 1.5% | 1.4% | ||||||||||
Bristol-Myers Squibb (Large-Cap Biopharma) — % of Annualized Base Rent(%) | 1.5% | 1.5% | 1.5% | ||||||||||
Northside Hospital (Health System) — % of Annualized Base Rent(%) | 1.5% | 1.4% | 1.4% | ||||||||||
Revolution Medicines (Large-Cap Biopharma) — % of Annualized Base Rent(%) | 1.5% | 1.4% | 1.4% | ||||||||||
Ascension Health (Health System) — % of Annualized Base Rent(%) | 1.0% | 1.2% | 1.3% | ||||||||||
Novo Nordisk (Large-Cap Biopharma) — % of Annualized Base Rent(%) | 1.3% | 1.2% | 1.2% | ||||||||||
University of Louisville (Health System) — % of Annualized Base Rent(%) | 1.4% | 1.5% | 1.2% | ||||||||||
Johnson & Johnson (Large-Cap Biopharma) — % of Annualized Base Rent(%) | 1.2% | 1.2% | 1.2% | ||||||||||
Pfizer (Large-Cap Biopharma) — % of Annualized Base Rent(%) | 1.0% | 0.9% | 1.0% | ||||||||||
Diluted FFO as Adjusted Applicable to Common Shares($M)7 | 309 | 325 | 317 | 332 | 323 | 326 | 330 | 329 | 321 | 320 | 277 | 253 | |
Diluted FFO as Adjusted per Common Share($) | 0.44 | 0.46 | 0.45 | 0.47 | 0.46 | 0.46 | 0.46 | 0.46 | 0.45 | 0.45 | 0.45 | 0.46 | |
FFO as Adjusted (Basic)($M) | 305 | 321 | 312 | 327 | 319 | 321 | 325 | 325 | 316 | 316 | 275 | 250 | |
Diluted Nareit FFO($M) | 301 | 323 | 302 | 333 | 323 | 308 | 323 | 311 | 316 | 319 | 162 | 264 | |
Diluted Nareit FFO per Common Share($) | 0.43 | 0.46 | 0.42 | 0.47 | 0.45 | 0.43 | 0.45 | 0.44 | 0.44 | 0.44 | 0.27 | 0.48 | |
Weighted Average Diluted Shares (FFO)(M) | 704 | 704 | 709 | 709 | 710 | 710 | 714 | 715 | 715 | 718 | 611 | 555 | |
General & Administrative Expense — Healthpeak($M) | 18.3 | 18.7 | 21.3 | 23.6 | 19.9 | 20.8 | |||||||
General & Administrative Expense — Janus Living($M) | 5.31 | 3.81 | 3.29 | ||||||||||
Total Capital Expenditures (Portfolio at Share)($M)10 | 174 | 156 | 121 | 244 | |||||||||
AFFO Capital Expenditures (Recurring + 2nd-Gen TI/LC)($M) | 37.6 | 42.1 | 24.0 | 57.8 | 27.3 | 25.7 | 23.1 | 39.0 | 23.5 | 35.7 | 17.5 | 47.3 | |
Recurring Capital Expenditures($M) | 13.6 | 11.8 | 8.15 | 28.0 | |||||||||
Tenant Improvements & Leasing Commissions($M) | 20.5 | 26.1 | 17.6 | ||||||||||
Revenue-Enhancing Capital Expenditures($M) | 65.0 | 46.8 | 16.5 | 47.5 | |||||||||
Development Capital Expenditures($M) | 24.5 | 20.3 | 2.13 | 40.2 | |||||||||
Redevelopment Capital Expenditures($M) | 27.5 | 29.8 | 34.8 | 34.8 | |||||||||
Capitalized Interest($M) | 17.7 | 19.6 | 19 | ||||||||||
Outpatient Medical Segment CapEx($M) | 77.6 | 57.4 | 49.5 | 112 | |||||||||
Lab Segment CapEx($M) | 77.3 | 79.9 | 60.9 | 84.8 | |||||||||
Senior Housing Segment CapEx($M) | 17.5 | 18.1 | 10.7 | 42.8 | |||||||||
Active Development & Redevelopment Pipeline — Estimated Total Cost($M)2 | 684 | 750 | 891 | ||||||||||
Estimated Cost to Complete($M) | 275 | 303 | 352 | ||||||||||
Projected Stabilized Portfolio Adjusted NOI($M) | 71 | 78 | 83 | ||||||||||
Net Debt to Adjusted EBITDAre(×)16 | 4.70 | 4.70 | 5.40 | 5.20 | 5.30 | 5.20 | 5.20 | 5.20 | 5.10 | 5.20 | 5.20 | 5.20 | |
Adjusted EBITDAre (Quarterly)($M) | 473 | 455 | 433 | 454 | 428 | 438 | 428 | 414 | 411 | 418 | |||
Annualized Adjusted EBITDAre($M) | 1,891 | 1,822 | 1,734 | 1,814 | 1,714 | 1,752 | |||||||
Adjusted Fixed Charge Coverage Ratio(×) | 4.40 | 4.00 | 3.90 | 4.30 | 4.20 | 4.40 | 4.40 | ||||||
Financial Leverage Ratio (Enterprise Debt / Gross Assets)(%) | 34.2% | 37.8% | 39.0% | 38.5% | 36.9% | 36.4% | 35.9% | ||||||
Secured Debt Ratio(%) | 1.2% | 1.2% | 1.7% | 2.1% | 2.2% | 2.2% | 2.1% | ||||||
Enterprise Debt (Pro Rata Share)($M) | 9,604 | 10,244 | 10,635 | 10,058 | 9,332 | 9,241 | 9,062 | ||||||
Enterprise Gross Assets($M) | 28,056 | 27,121 | 27,254 | 26,150 | 25,266 | 25,370 | |||||||
Total Available Liquidity($M) | 4,175 | 4,131 | 3,420 | 2,389 | 2,723 | 2,314 | |||||||
Credit Facilities Capacity & Term Loans($M) | 5,150 | 4,000 | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 | ||||||
Commercial Paper Balance Outstanding($M) | 1,490 | 1,496 | 1,751 | 1,079 | 368 | 775 | 164 | ||||||
Total Floating-Rate Debt($M) | 1,608 | 1,612 | 1,867 | 1,193 | 542 | 888 | |||||||
Floating-Rate Share of Enterprise Debt(%) | 16.5% | 15.6% | 17.4% | 11.7% | 5.7% | 9.5% | 2.9% | ||||||
Weighted Average Interest Rate (GAAP)(%) | 4.3% | 4.2% | 4.2% | 4.2% | 4.3% | 4.3% | 4.2% | ||||||
Weighted Average Coupon Rate(%) | 3.9% | 3.9% | 3.9% | 3.9% | 3.9% | 3.9% | 3.9% | ||||||
Quarterly Cash Dividends Declared per Common Share($) | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | ||||||
Market Value of Healthpeak's 214.7M Shares/Units in Janus Living($M) | 6,363 | 6,345 | 5,652 | ||||||||||
Janus Living (NYSE: JAN) — Total Senior Housing Communities2 | 74 | 41 | 40 | 34 | 34 | 34 | 34 | ||||||
Same-Store Pool Communities | 15 | 15 | 15 | 15 | 15 | 15 | 15 | ||||||
Life Care Services (LCS) Operated Communities3 | 15 | 15 | 15 | ||||||||||
LCS Share of Janus Living Adjusted NOI(%) | 56.6% | 69.6% | 65.8% | ||||||||||
Sunrise Senior Living Operated Communities | 2 | 2 | 2 | ||||||||||
Sunrise Share of Janus Living Adjusted NOI(%) | 8.7% | 11.0% | 12.6% | ||||||||||
Janus Living — Total Portfolio Occupancy Rate1 | |||||||||||||
Same-Store Total Occupancy Rate3 | |||||||||||||
Same-Store Independent Living Occupancy Rate(%) | 89.4% | 88.5% | 88.0% | 86.9% | 86.1% | 85.0% | 84.7% | ||||||
Same-Store Assisted Living & Memory Care Occupancy Rate(%) | 92.3% | 91.5% | 91.5% | 91.1% | 90.1% | 89.5% | 89.3% | ||||||
Same-Store Skilled Nursing Occupancy Rate(%) | 88.0% | 85.6% | 87.4% | 85.4% | 85.7% | 86.4% | 89.1% | ||||||
Janus Living — Same-Store Monthly RevPOR (Incl. NREF Amortization)1 | |||||||||||||
Total Portfolio NREF Cash Collections($M)3 | 46.5 | 40.7 | 35.0 | 44.5 | 36.9 | 42.7 | |||||||
Total Portfolio GAAP NREF Amortization($M) | 29.8 | 27.8 | 27.2 | 27.1 | 24.2 | 23.7 | |||||||
Same-Store NREF Cash Collections($M) | 46.2 | 40.5 | 35.0 | 44.5 | 36.9 | 42.7 | 28.7 | ||||||
Same-Store GAAP NREF Amortization($M) | 29.2 | 27.8 | 27.2 | 27.1 | 24.2 | 23.7 | 24.0 | ||||||
Janus Living — Total Portfolio Cash (Adjusted) NOI($M)4 | 75.6 | 57.7 | 56.5 | 47.2 | 41.8 | 42.2 | 44.4 | ||||||
Total Portfolio Cash NOI Margin(%) | 28.2% | 26.6% | 27.8% | 26.6% | 24.2% | 24.6% | 25.9% | ||||||
Total Resident Fees & Services Cash Revenue (Excl. NREF)($M) | 268 | 216 | 203 | 178 | 173 | 171 | 171 | ||||||
Total Portfolio Labor Expense($M) | 109 | 90.6 | 84.1 | 76.0 | 75.0 | 74.2 | 73.6 | ||||||
Same-Store Cash (Adjusted) NOI($M)3 | 46.1 | 43.7 | 44.0 | 42.2 | 36.6 | 36.6 | |||||||
Same-Store Cash NOI Margin(%) | 27.9% | 27.1% | 27.5% | 27.1% | 24.3% | 24.6% | 26.0% | ||||||
Same-Store Resident Fees & Services Revenue($M) | 165 | 161 | 160 | 156 | 150 | 149 | 149 | ||||||
Same-Store Labor Expense($M) | 68.8 | 67.9 | 67.7 | 66.9 | 65.9 | 65.2 | 64.6 | ||||||
Janus Living — Standalone Diluted FFO as Adjusted($M)20 | 75.9 | 64.0 | 49.9 | 41.0 | 36.8 | 36.2 | |||||||
Standalone Diluted FFO as Adjusted per Share($) | 0.25 | 0.24 | 0.23 | 0.19 | 0.17 | 0.17 | |||||||
Standalone Diluted Nareit FFO($M) | 73.1 | 65.6 | 33.6 | 37.1 | 33.4 | 35.4 | |||||||
Standalone Diluted Nareit FFO per Share($) | 0.24 | 0.24 | 0.15 | 0.17 | 0.16 | 0.16 | |||||||
Standalone Adjusted EBITDAre($M) | 105 | 79.5 | 65.2 | 63.0 | 52.2 | 59.5 | |||||||
Standalone GAAP Net Income (Loss)($M) | -5.61 | 14.9 | 27.9 | 9.62 | 1.41 | -2.57 | |||||||
Related-Party Management Fee Paid to Healthpeak($M) | 3.78 | 2.47 | 0.33 | ||||||||||
Standalone Direct General & Administrative Expense($M) | 1.53 | 1.33 | 2.96 | 2.77 | 2.27 | 2.38 | 3.13 | ||||||
Standalone AFFO Capital Expenditures($M) | 7.16 | 5.28 | 3.40 | 11.6 | 5.76 | 3.28 | 0.29 | ||||||
Standalone Revenue-Enhancing Capital Expenditures($M) | 15.7 | 16.9 | 6.47 | 22.0 | 14.0 | 12.9 | 5.59 | ||||||
Standalone Operating Cash Flow($M) | 112 | 79.6 | 33.3 | 42.8 | 23.7 | 49.5 | 20.8 | ||||||
Standalone Net Real Estate Investments($M) | 4,097 | 2,594 | 2,521 | 1,654 | 1,605 | ||||||||
Standalone Total Assets($M) | 5,220 | 4,710 | 4,024 | 2,342 | 2,343 | ||||||||
Standalone Cash & Cash Equivalents($M) | 338 | 1,558 | 949 | 19.7 | 19.5 | 22.6 | |||||||
Standalone Available Liquidity($M) | 1,588 | 2,158 | 1,549 | 19.7 | 19.4 | 22.6 | 21.2 | ||||||
Janus Living Total Enterprise Value($M) | 9,194 | 8,389 | 6,202 | ||||||||||
Janus Living Period-End Share Price($) | 29.63 | 28.74 | 23.57 | ||||||||||
Janus Living FY 2026 FFO as Adjusted / Share Guidance (Low)($) | 0.97 | 0.95 | 0.93 | ||||||||||
Janus Living FY 2026 FFO as Adjusted / Share Guidance (High)($) | 0.99 | 0.98 | 0.97 | ||||||||||
Janus Living FY 2026 SS Cash NOI Growth Guidance (Low)(%) | 16.0% | 13.0% | 11.0% | ||||||||||
Janus Living FY 2026 SS Cash NOI Growth Guidance (High)(%) | 19.0% | 17.0% | -15.0% | ||||||||||
Alexandria Real Estate Equities, Inc. (ARE) — Total Revenues($M)3 | 642 | 630 | 642 | 714 | 724 | 724 | 732 | 750 | 765 | 746 | 747 | 734 | |
Alexandria Real Estate Equities, Inc. (ARE) — Net Real Estate Investments($M) | 28,427 | 29,126 | 28,830 | 28,690 | 31,744 | 32,161 | 32,122 | 32,110 | 32,952 | 32,674 | 32,323 | 31,634 | |
Alexandria Real Estate Equities, Inc. (ARE) — Operating Cash Flow($M) | 342 | 337 | 197 | 312 | 434 | 460 | 208 | 274 | 477 | 412 | 341 | 429 | |
Alexandria Real Estate Equities, Inc. (ARE) — Total Assets($M) | 34,052 | 34,632 | 34,167 | 34,082 | 37,375 | 37,624 | 37,600 | 37,527 | 38,488 | 37,848 | 37,699 | 36,771 | |
Healthcare Realty Trust Incorporated (HR) — Total Revenues($M)3 | 287 | 282 | 279 | 286 | 298 | 298 | 299 | 310 | 315 | 316 | 327 | 330 | |
Healthcare Realty Trust Incorporated (HR) — Net Real Estate Investments($M) | 7,613 | 7,745 | 7,820 | 7,895 | 8,010 | 8,675 | 9,211 | 9,327 | 9,898 | 10,435 | 11,035 | 11,172 | |
Healthcare Realty Trust Incorporated (HR) — Operating Cash Flow($M) | 122 | 142 | 52.9 | 132 | 114 | 163 | 47.8 | 138 | 119 | 168 | 76.2 | 127 | |
Healthcare Realty Trust Incorporated (HR) — Total Assets($M) | 8,960 | 9,001 | 9,148 | 9,211 | 9,860 | 10,236 | 10,496 | 10,651 | 11,245 | 11,804 | 12,281 | 12,637 | |
Welltower Inc. (WELL) — Total Revenues($M)3 | 3,716 | 3,545 | 3,352 | 3,181 | 2,686 | 2,548 | 2,423 | 2,251 | 2,056 | 1,825 | 1,860 | 1,750 | |
Welltower Inc. (WELL) — Net Real Estate Investments($M) | 61,245 | 58,054 | 53,155 | 53,423 | 45,328 | 44,301 | 43,083 | 40,673 | 39,200 | 37,219 | 36,983 | 37,063 | |
Welltower Inc. (WELL) — Operating Cash Flow($M) | 1,003 | 1,004 | 670 | 654 | 858 | 770 | 599 | 559 | 685 | 605 | 407 | 371 | |
Welltower Inc. (WELL) — Total Assets($M) | 73,711 | 69,875 | 67,221 | 67,303 | 59,505 | 55,834 | 53,294 | 51,044 | 48,954 | 45,534 | 44,554 | 44,012 | |
Ventas, Inc. (VTR) — Total Revenues($M)2 | 1,832 | 1,730 | 1,657 | 1,566 | 1,489 | 1,421 | 1,358 | 1,287 | 1,236 | 1,201 | 1,200 | 1,164 | |
Ventas, Inc. (VTR) — Operating Cash Flow($M) | 490 | 557 | 395 | 472 | 379 | 475 | 321 | 374 | 354 | 336 | 266 | 279 | |
Ventas, Inc. (VTR) — Total Assets($M) | 30,625 | 29,656 | 27,687 | 27,592 | 26,926 | 26,475 | 26,032 | 26,187 | 25,347 | 24,530 | 24,673 | 24,725 | |
Omega Healthcare Investors, Inc. (OHI) — Total Revenues($M)3 | 341 | 328 | 323 | 319 | 312 | 283 | 277 | 279 | 276 | 253 | 243 | 239 | |
Omega Healthcare Investors, Inc. (OHI) — Net Real Estate Investments($M) | 6,565 | 6,468 | 6,470 | 6,703 | 6,742 | 6,795 | 6,333 | 6,339 | 6,292 | 5,877 | 5,834 | 5,903 | |
Omega Healthcare Investors, Inc. (OHI) — Operating Cash Flow($M) | 191 | 218 | 216 | 231 | 227 | 239 | 182 | 229 | 185 | 184 | 152 | 165 | |
Omega Healthcare Investors, Inc. (OHI) — Total Assets($M) | 10,121 | 10,015 | 10,235 | 10,049 | 10,596 | 10,547 | 9,706 | 9,898 | 9,572 | 8,849 | 9,012 | 9,117 | |
U.S. Healthcare Construction Spending (SAAR)1 | |||||||||||||
U.S. Vacant Housing Units for Rent (Census HVS) | 3,866.00 | 3,727.00 | 3,674.00 | 3,561.00 | 3,547.00 | 3,546.00 | 3,533.00 | 3,393.00 | 3,409.00 | 3,241.00 | 3,184.00 | 3,220.00 | |
Total Consolidated Revenues (GAAP)($M)6 | 821 | 772 | 753 | 719 | 706 | 694 | 703 | 698 | 700 | 696 | 607 | 554 | |
Total Costs and Expenses($M) | 795 | 739 | 747 | 661 | 653 | 652 | 643 | 668 | 665 | 666 | 666 | 496 | |
General and Administrative Expense (Consolidated)($M) | 23.6 | 22.5 | 24.6 | 23.6 | 19.9 | 20.8 | 26.1 | 23.9 | 23.2 | 26.7 | 23.3 | 21.6 | |
Interest Expense($M) | 83.9 | 92.3 | 87.3 | 80.6 | 76.8 | 75.1 | 72.7 | 70.5 | 74.1 | 74.9 | 60.9 | 52.8 | |
Depreciation and Amortization($M) | 299 | 283 | 290 | 262 | 262 | 266 | 269 | 275 | 280 | 284 | 219 | 189 | |
Net Income Attributable to Common Stockholders($M) | 17.1 | 52.7 | 194 | 114 | -117 | 31.6 | 42.4 | 4.40 | 85.7 | 146 | 6.50 | 70.8 | |
Diluted Earnings per Common Share (GAAP)($) | 0.02 | 0.08 | 0.28 | 0.16 | -0.17 | 0.05 | 0.06 | 0 | 0.12 | 0.21 | 0.01 | 0.13 | |
Total Consolidated Assets($M)5 | 22,412 | 21,680 | 21,616 | 20,336 | 19,582 | 19,810 | 19,816 | 19,938 | 19,970 | 20,180 | 20,542 | 15,699 | |
Net Real Estate Investments($M) | 18,489 | 16,864 | 16,837 | 16,099 | 15,831 | 15,820 | 15,840 | 15,831 | 15,892 | 16,398 | 16,663 | 13,028 | |
Cash and Cash Equivalents($M) | 514 | 1,627 | 1,171 | 468 | 91 | 89.4 | 70.6 | 120 | 180 | 107 | 102 | 118 | |
Total Liabilities($M) | 11,607 | 12,182 | 12,556 | 12,034 | 11,317 | 11,223 | 10,972 | 10,881 | 10,748 | 10,761 | 10,943 | 8,774 | |
Healthpeak Stockholders' Equity($M) | 7,866 | 7,845 | 7,826 | 7,500 | 7,597 | 7,928 | 8,188 | 8,401 | 8,563 | 8,758 | 8,882 | 6,350 | |
Noncontrolling Interests (Incl. Janus Living Public Float & JVs)($M) | 2,912 | 1,626 | 1,207 | 643 | 640 | 639 | 641 | 654 | 658 | 660 | 663 | 526 | |
Net Cash Provided by Operating Activities($M)4 | 355 | 361 | 261 | 294 | 315 | 364 | 279 | 284 | 318 | 316 | 153 | 231 | |
Net Cash Used in Investing Activities($M) | -2,073 | 133 | -639 | -406 | -188 | -210 | -231 | -234 | 30.2 | 188 | -97.8 | -216 | |
Net Cash Provided by (Used in) Financing Activities($M) | 606 | -41 | 1,106 | 490 | -130 | -129 | -94.4 | -108 | -266 | -502 | -66.6 | 39.5 | |
Cash Dividends Paid on Common Stock($M) | 210 | 210 | 212 | 212 | 212 | 212 | 214 | 210 | 210 | 211 | 164 | 164 | |
Common Stock Repurchases($M) | 0.10 | 100 | 1.40 | 0.10 | 0 | 72.1 | 25 | 0.30 | 20.1 | 68.2 | 102 | 0 | |
37 chỉ số không có số liệu trong 12 quý gần nhất — .
In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).
Phương pháp và các chỉ số bị loại
- Các dòng ở Cốt lõi lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K và 10-Q (XBRL), có liên kết tới từng hồ sơ. Số quý 4 bằng cả năm tài chính trừ chín tháng đầu (hiện bằng chữ in nghiêng).
- Fiscal year ends December 31; latest company-reported period is Q3 2026 (ended September 30, 2026, filed November 2–3, 2026).
- On March 1, 2024, Healthpeak completed its all-stock merger with Physicians Realty Trust (NYSE: DOC) and changed its NYSE ticker symbol from PEAK to DOC, expanding the Outpatient Medical portfolio by nearly 300 properties.
- In March 2026, Healthpeak completed the IPO of its senior housing portfolio as Janus Living, Inc. (NYSE: JAN); Healthpeak retained 214.7 million common shares and OP units (~74.5%–81% economic ownership during 2026) and continues to consolidate Janus Living under US GAAP.
- Healthpeak operates under a US GAAP UPREIT structure without standalone parent operating financial statements; pro rata share metrics are reported directly in the Quarterly Supplemental Reports.
Không hiện vì thiếu các kỳ gần đây (5)
- Adjusted Funds From Operations (AFFO) — Discontinued in Healthpeak's redesigned Q1 2026 Supplemental Report; AFFO Capital Expenditures and FFO as Adjusted continue to be reported.
- Triple-Net Lease Operator EBITDARM Coverage — Discontinued following Healthpeak's 2020–2021 exit from triple-net senior housing and skilled nursing leases.
- Scope 3 Value-Chain GHG Emissions (395,717 mtCO2e in FY2025) — Excluded from multi-year series due to methodology and category expansion in FY2025 lacking comparable restated FY2024 figures.
- New Janus Living Operators Added in Q2–Q3 2026 (Pegasus, Ciel, Holbrook, Cedarhurst) — Excluded until three consecutive quarters of standalone history accumulate.
- Narrative Approximate Figures (e.g., 'approximately $25 billion portfolio', 'more than 40 years', 'less than 1%') — Excluded because approximate bounds are not exact point disclosures.
Dữ liệu cập nhật 2026-11-14.
Mỗi KPI một trang riêng
Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số
Portfolio Scale & Occupancy Across Healthcare Real Estate
- Total Portfolio Properties11 kỳ
- Outpatient Medical — Total Rentable Capacity (nghìn ft²)11 kỳ
- Lab — Total Rentable Capacity (nghìn ft²)23 kỳ
- Senior Housing — Total Portfolio Units11 kỳ
- Outpatient Medical — Portfolio Occupancy Rate (%)11 kỳ
- Lab — Portfolio Occupancy Rate (%)23 kỳ
- Senior Housing — Portfolio Occupancy Rate (%)11 kỳ
Leasing Velocity, Retention & Mark-to-Market Rent Spreads
Same-Store Cash NOI Growth, Segment NOI & Full-Year Guidance
Geographic Biotech Hubs & Top Tenant Credit Mix
FFO, Capital Deployment, Pipeline & Balance Sheet Leverage
Janus Living, Inc. (NYSE: JAN) — Consolidated Senior Housing Subsidiary
- Janus Living (NYSE: JAN) — Total Senior Housing Communities7 kỳ
- Janus Living — Total Portfolio Occupancy Rate (%)0 kỳ
- Janus Living — Same-Store Monthly RevPOR (Incl. NREF Amortization) ($)0 kỳ
- Janus Living — Total Portfolio Cash (Adjusted) NOI ($M)7 kỳ
- Janus Living — Standalone Diluted FFO as Adjusted ($M)6 kỳ
Sustainability, Green Building Certifications & Workforce
Healthcare, Life Science & REIT External Benchmarks
- Alexandria Real Estate Equities, Inc. (ARE) — Total Revenues ($M)27 kỳ
- Healthcare Realty Trust Incorporated (HR) — Total Revenues ($M)27 kỳ
- Welltower Inc. (WELL) — Total Revenues ($M)27 kỳ
- Ventas, Inc. (VTR) — Total Revenues ($M)27 kỳ
- Omega Healthcare Investors, Inc. (OHI) — Total Revenues ($M)27 kỳ
- U.S. Ambulatory Health Care Services Employment (BLS SA)142 kỳ
- U.S. CPI — Medical Care Services (1982–84 = 100, SA)141 kỳ
- U.S. Healthcare Construction Spending (SAAR) ($M)141 kỳ
Tài liệu nguồn mới nhất
Các tài liệu được trích nhiều nhất cho số liệu mới nhất của Healthpeak Properties
- Healthpeak Q3 2026 Supplemental Report (Form 8-K) ↗
- Janus Living, Inc. Q3 2026 Supplemental Report (Form 8-K) ↗
- 2025 Corporate Impact Report (GRI Data Tables) ↗
- Healthpeak Form 10-Q (filed 2026-11-03) ↗
- Healthpeak Form 10-K (filed 2026-02-03) ↗
- Healthpeak Q4 2023 Supplemental Report (Form 8-K) ↗
- Healthpeak Q4 2025 Earnings Release (Form 8-K) ↗
- Healthpeak Q4 2025 Supplemental Report (Form 8-K) ↗
- Form 10-K FY2025 ↗
- Alexandria Real Estate Equities, Inc. (ARE) Form 10-Q (filed 2026-10-26) ↗
- Alexandria Real Estate Equities, Inc. (ARE) Form 10-K (filed 2026-01-26) ↗
- Healthcare Realty Trust Incorporated (HR) Form 10-Q (filed 2026-10-29) ↗
See a number that looks wrong?